Page 215 - Read Online
P. 215

Zhang et al. J Cancer Metastasis Treat 2018;4:16  I  http://dx.doi.org/10.20517/2394-4722.2018.01                             Page 7 of 11































               Figure 5. Forest plots of PD-1 expression and the clinical pathological parameters of patients with solid tumors. The squares and
               horizontal lines correspond to the study-specific OR and 95% CI. The area of the square reflects the study-specific weight. The diamonds
               represents the pooled OR and 95% CI. The solid vertical line is at the null value (OR = 1). The associations of PD-1 expression with lymph
               node status (A) and tumor grade (B) are shown. PD-1: programmed cell death protein 1; OR: odds ratio; CI: confidence interval

               Table 3. Associations of PD-1 expression and clinical features

               Variables           No. of study    OR ( 95% CI)    Z, P (OR)  Heterogeneity     Publication bias  Pooling model
                                                                        2
                                                                         (I , P bias)  (Egger test) (t, P)
               Age (years): ≤ 65 vs. > 65   2  1.20 (0.48-3.02)  0.39, 0.70  73%, 0.06  -         Random
               Gender: male vs. female  3    0.96 (0.78-1.18)  0.36, 0.72  0%, 0.81  0.42, 0.748  Fixed
               T: T3/T4 vs. T1/T2      4     1.17 (0.61-2.24)  0.48, 0.64  91%, 0.000  0.57, 0.627  Random
               Lymph node metastasis:   4    2.55 (1.22-2.59)  2.05, 0.01*  82%, 0.0008  1.09, 0.389  Random
               yes vs. no
               Tumor grade: 3/4 vs. 1/2  3   3.08 (2.07-4.57)  5.56, < 0.0001*  0%, 0.92  0.12, 0.923  Fixed
               TNM stage: III/IV vs. I/II  4  1.04 (0.71-1.54)  0.21, 0.84  0%, 0.93  3.38, 0.077  Fixed
               *Statistical significance. PD-1: programmed cell death protein 1; OR: odds ratio; CI: confidence interval

               596 grade 1/2 tissues (15.8%) (OR = 3.08, 95% CI: 2.07-4.57, P < 0.00001) [Figure 5B]. We did not find the
               significant association of PD-1 with age, TNM stage or tumor invasion depth in solid tumor [Table 3].


               Publication bias
               Begg’s and Egger’s test were applied to evaluate the publication bias of the included studies. No obvious
               asymmetry was presented through the visual assessment of the Begg’s funnel plots [Figure 6]. Furthermore,
               the formal evaluation of Egger’s test also failed to find the significant bias (P = 0.723).


               Sensitivity analysis
               Sensitivity analysis was conducted to justify the influence of individual study on the synthetic results of
               OS. The pooled HR was not significantly influenced after omitting any singly study for the effect of PD-1
               expression on OS in our study [Figure 7].


               DISCUSSION
               PD-1, as one of the co-inhibitory receptors, plays an important role in cancer immunity equilibrium and
               immunity escape stages . In the present study, we comprehensively assessed the association of PD-1
                                    [26]
   210   211   212   213   214   215   216   217   218   219   220